Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
5.66
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
4.33
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
0.09
General Information
Revision date
2020-03-27
Product name
THERAFLU SINUS AND PAIN
Product Synonyms
THERAFLU FLU AND SORE THROAT POWDER FOR SOLUTION (PARACETAMOL 650MG + PHENIRAMINE MALEATE 20MG + PHENYLEPHRINE HYDROCHLORIDE 10MG) US * MFC1421
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Combustible dusts Category 1
Health hazards
Serious eye damage/eye irritation Category 2 Sensitization, skin Category 1
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air. May cause an allergic skin reaction. Causes serious eye irritation.
Prevention
Prevent dust accumulation to minimize explosion hazard. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Keep container tightly closed. Ground and bond container and receiving equipment. Avoid breathing dust. Wash thoroughly after handling. Contaminated work clothing should not be allowed out of the workplace. Wear eye protection/face protection. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of water/soap. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Specific treatment (see instructions on this label). If skin irritation or rash occurs: Get medical advice/attention. If eye irritation persists: Get medical advice/attention. Take off contaminated clothing and wash it before reuse. In case of fire: Use appropriate media to extinguish.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards. Assume that this product is capable of sustaining combustion. Product may form explosive dust/air mixture if high concentration of product dust is suspended in air.
Additional information
4 % of the mixture consists of component(s) of unknown acute oral toxicity. 96.87 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 93.54 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 93.54 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
